{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:17:53Z","timestamp":1791555473288,"version":"4.3.4"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglial receptor exclusively expressed in the central nervous system (CNS). It contributes to abnormal protein aggregation in neurodegenerative disorders, but its role in Parkinson\u2019s disease (PD) is still unclear.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> In this case-control study, we measured the concentration of the soluble fragment of TREM2 (sTREM2) in PD patients, evaluated their sleep conditions by the PD sleep scale (PDSS), and analyzed the relationship between sTREM2 and PD symptoms.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> We recruited 80 sporadic PD patients and 65 healthy controls without disease-related variants in TREM2. The concentration of sTREM2 in the CSF was significantly higher in PD patients than in healthy controls (<jats:italic>p<\/jats:italic> &amp;lt; 0.01). In the PD group, the concentration of sTREM2 had a positive correlation with \u03b1-syn in the CSF (Pearson <jats:italic>r<\/jats:italic> = 0.248, <jats:italic>p<\/jats:italic> = 0.027). Receiver operating characteristic curve (ROC) analyses showed that sTREM2 in the CSF had a significant diagnostic value for PD (AUC, 0.791; 95% CI, 0.711\u20130.871, <jats:italic>p<\/jats:italic> &amp;lt; 0.05). The subgroup analysis showed that PD patients with sleep disorders had a significantly higher concentration of sTREM2 in their CSF (<jats:italic>p<\/jats:italic> &amp;lt; 0.01). The concentration of sTREM2 in the CSF had a negative correlation with the PDSS score in PD patients (Pearson <jats:italic>r<\/jats:italic> = \u22120.555, <jats:italic>p<\/jats:italic> &amp;lt; 0.01). The ROC analyses showed that sTREM2 in the CSF had a significant diagnostic value for sleep disorders in PD (AUC, 0.733; 95% CI, 0.619\u20130.846, <jats:italic>p<\/jats:italic> &amp;lt; 0.05).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Our findings suggest that CSF sTREM2 may be a potential biomarker for PD and it could help predict sleep disorders in PD patients, but multicenter prospective studies with more participants are still needed to confirm its diagnostic value in future.<\/jats:p>","DOI":"10.3389\/fnagi.2021.753210","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T06:47:15Z","timestamp":1632898035000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Soluble Triggering Receptor Expressed on Myeloid Cells 2 From Cerebrospinal Fluid in Sleep Disorders Related to Parkinson\u2019s Disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Mingshu","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiewen","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyou","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanqun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuyan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panghai","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuohua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3389\/fncel.2017.00250","article-title":"Roles of Microglial Phagocytosis and Inflammatory Mediators in the Pathophysiology of Sleep Disorders.","volume":"11","author":"Agnes","year":"2017","journal-title":"Front. Cell Neurosci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1523\/JNEUROSCI.5156-05.2006","article-title":"Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter.","volume":"26","author":"Alexandre","year":"2006","journal-title":"J. Neurosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"651157","DOI":"10.3389\/fneur.2021.651157","article-title":"Probable REM Sleep Behavior Disorder Is a Risk Factor for Symptom Progression in Parkinson Disease.","volume":"12","author":"Barasa","year":"2021","journal-title":"Front. Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jneuroim.2018.03.003","article-title":"Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease.","volume":"319","author":"Bekris","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fasebj.2020.34.s1.01844","article-title":"Interaction of sTREM2 with Amyloid Beta: implication on the Protective Role of sTREM2 in Alzheimer\u2019s Disease.","volume":"34","author":"Belsare","year":"2020","journal-title":"FASEB J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","article-title":"Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism.","volume":"76","author":"Block","year":"2005","journal-title":"Prog. Neurobiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.biopsych.2017.11.031","article-title":"The Emerging Relationship Between Interstitial Fluid-Cerebrospinal Fluid Exchange, Amyloid-\u03b2, and Sleep.","volume":"83","author":"Boespflug","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fnagi.2017.00008","article-title":"Increase of TREM2 during Aging of an Alzheimer\u2019s Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis.","volume":"9","author":"Brendel","year":"2017","journal-title":"Front. Aging Neurosci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management.","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"eaam6003","DOI":"10.1126\/scitranslmed.aam6003","article-title":"Finding useful biomarkers for Parkinson\u2019s disease.","volume":"10","author":"Chen-Plotkin","year":"2018","journal-title":"Sci. Transl. Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia Function in the Central Nervous System During Health and Neurodegeneration.","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu. Rev. Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3233\/JAD-201548","article-title":"Significant overlap of \u03b1-synuclein, amyloid-\u03b2, and phospho-tau pathologies in neuropathological diagnosis of lewy-related pathology.","volume":"80","author":"Cong","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/ni.3166","article-title":"TREM2 function in microglia.","volume":"16","author":"Dempsey","year":"2015","journal-title":"Nat. Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S1474-4422(16)00080-6","article-title":"Assessment of \u03b1-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.","volume":"15","author":"Dolores","year":"2016","journal-title":"Lancet Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-017-1684-z","article-title":"Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson\u2019s disease.","volume":"133","author":"Doppler","year":"2017","journal-title":"Acta Neuropathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10571-019-00649-9","article-title":"\u03b1-Synuclein and Glia in Parkinson\u2019s Disease: a Beneficial or a Detrimental Duet for the Endo-Lysosomal System?.","volume":"39","author":"Filippini","year":"2019","journal-title":"Cell Mol. Neurobiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bbi.2014.11.009","article-title":"Microglia inflammatory responses are controlled by an intrinsic circadian clock.","volume":"45","author":"Fonken","year":"2015","journal-title":"Brain Behav. Immun"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/mds.28019","article-title":"Lack of Asymmetry of Nigrostriatal Dopaminergic Function in Healthy Subjects.","volume":"35","author":"Garrido","year":"2020","journal-title":"Mov. Disord"},{"key":"B19","doi-asserted-by":"publisher","first-page":"656426","DOI":"10.3389\/fncel.2021.656426","article-title":"Lymphocyte Activation Gene 3 (Lag3) Contributes to \u03b1-Synucleinopathy in \u03b1-Synuclein Transgenic Mice.","volume":"15","author":"Gu","year":"2021","journal-title":"Front. Cell Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12974-019-1654-6","article-title":"Association of LAG3 genetic variation with an increased risk of PD in Chinese female population.","volume":"16","author":"Guo","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"B21","doi-asserted-by":"publisher","first-page":"12164","DOI":"10.1096\/fj.201900992R","article-title":"TREM2 deficiency aggravates \u03b1-synuclein-induced neurodegeneration and neuroinflammation in Parkinson\u2019s disease models.","volume":"33","author":"Guo","year":"2019","journal-title":"FASEB J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"eaaz4232","DOI":"10.1126\/sciadv.aaz4232","article-title":"Locus coeruleus norepinephrine activity mediates sensory-evoked awakenings from sleep.","volume":"6","author":"Hayat","year":"2020","journal-title":"Sci. Adv"},{"key":"B23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13195-016-0182-1","article-title":"Cerebrospinal fluid soluble TREM2 in aging and Alzheimer\u2019s disease.","volume":"8","author":"Henjum","year":"2016","journal-title":"Alzheimers Res. Ther"},{"key":"B24","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12974-018-1331-1","article-title":"CSF sTREM2 in delirium-relation to Alzheimer\u2019s disease CSF biomarkers A\u03b242, t-tau and p-tau.","volume":"15","author":"Henjum","year":"2018","journal-title":"J. Neuroinflamm"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1007\/s12640-021-00383-5","article-title":"Associations of Sleep Characteristics with Cerebrospinal Fluid sTREM2 in Cognitively Normal Older Adults: the CABLE Study.","volume":"39","author":"Hu","year":"2021","journal-title":"Neurotox Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"243ra86","DOI":"10.1126\/scitranslmed.3009093","article-title":"TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis.","volume":"6","author":"Kleinberger","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/jnc.15275","article-title":"Alpha-synuclein oligomerization and aggregation: all models are useful but only if we know what they model.","volume":"157","author":"Lashuel","year":"2021","journal-title":"J. Neurochem"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.neuron.2021.02.010","article-title":"Trem2 restrains the enhancement of tau accumulation and neurodegeneration by \u03b2-amyloid pathology.","volume":"109","author":"Lee","year":"2021","journal-title":"Neuron"},{"key":"B29","doi-asserted-by":"publisher","first-page":"11524","DOI":"10.1073\/pnas.1710311114","article-title":"TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy.","volume":"114","author":"Leyns","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B30","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.bbrc.2019.07.084","article-title":"Extracellular microvesicles-derived from microglia treated with unaggregated \u03b1-synuclein attenuate mitochondrial fission and toxicity-induced by Parkinsonian toxin MPP+.","volume":"517","author":"Li","year":"2019","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e009499","DOI":"10.1136\/bmjopen-2015-009499","article-title":"Association study of TREM2 polymorphism rs75932628 with leucoaraiosis or Parkinson\u2019s disease in the Han Chinese population.","volume":"6","author":"Li","year":"2016","journal-title":"BMJ Open"},{"key":"B32","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/bip.20550","article-title":"Secondary structural formation of alpha-synuclein amyloids as revealed by g-factor of solid-state circular dichroism.","volume":"83","author":"Lin","year":"2010","journal-title":"Biopolymers"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1093\/brain\/awz113","article-title":"Sleep and the risk of parkinsonism and Parkinson\u2019s disease: a population-based study.","volume":"42","author":"Lysen","year":"2019","journal-title":"Brain"},{"key":"B34","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3390\/ijms19010318","article-title":"Microglia and aging: the role of the TREM2-DAP12 and CX3CL1-CX3CR1 Axes.","volume":"19","author":"Mecca","year":"2018","journal-title":"Int. J. Mol. Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/mds.27094","article-title":"FDG PET, dopamine transporter SPECT, and olfaction: combining biomarkers in REM sleep behavior disorder.","volume":"32","author":"Meles","year":"2017","journal-title":"Mov. Disord"},{"key":"B36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.parkreldis.2015.11.026","article-title":"TREM2 rare variant p.R47H is not associated with Parkinson\u2019s disease.","volume":"23","author":"Mengel","year":"2016","journal-title":"Parkinsonism Relat. Disord"},{"key":"B37","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a Brief Screening Tool For Mild Cognitive Impairment.","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/s41380-018-0291-2","article-title":"The role of co-neurotransmitters in sleep and wake regulation.","volume":"24","author":"Oh","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"B39","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s12031-019-01424-7","article-title":"Analysis of Cerebrospinal Fluid Soluble TREM2 and Polymorphisms in Sporadic Parkinson\u2019s Disease in a Chinese Population.","volume":"70","author":"Peng","year":"2020","journal-title":"J. Mol. Neurosci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00401-016-1533-5","article-title":"Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status.","volume":"131","author":"Piccio","year":"2016","journal-title":"Acta Neuropathol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/mds.26077","article-title":"The Onset of Nonmotor Symptoms in Parkinson\u2019s disease (The ONSET PD Study).","volume":"30","author":"Pont-Sunyer","year":"2015","journal-title":"Mov. Disord"},{"key":"B42","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s13205-020-02532-7","article-title":"Mucuna pruriens in Parkinson\u2019s and in some other diseases: recent advancement and future prospective.","volume":"10","author":"Rai","year":"2020","journal-title":"3 Biotech"},{"key":"B43","doi-asserted-by":"publisher","first-page":"101752","DOI":"10.1016\/j.jchemneu.2020.101752","article-title":"Advancement in the modelling and therapeutics of Parkinson\u2019s disease.","volume":"104","author":"Rai","year":"2020","journal-title":"J. Chem. Neuroanat"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.4103\/1673-5374.306066","article-title":"Promising drug targets and associated therapeutic interventions in Parkinson\u2019s disease.","volume":"16","author":"Rai","year":"2021","journal-title":"Neural Regen. Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.expneurol.2018.01.016","article-title":"TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson\u2019s disease.","volume":"302","author":"Ren","year":"2018","journal-title":"Exp. Neurol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"201811411","DOI":"10.1073\/pnas.1811411115","article-title":"Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy.","volume":"115","author":"Sayed","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B47","doi-asserted-by":"publisher","first-page":"18076","DOI":"10.1074\/jbc.RA120.015319","article-title":"\u03b1-synuclein facilitates endocytosis by elevating the steady-state levels of phosphatidylinositol 4,5-bisphosphate.","volume":"295","author":"Schechter","year":"2020","journal-title":"J. Biol. Chem"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ng.3916","article-title":"Rare coding variants in PLCG2, ABI3, and TREM2implicate microglial-mediated innate immunity in Alzheimer\u2019s disease.","volume":"49","author":"Sims","year":"2017","journal-title":"Nat. Gene"},{"key":"B49","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41386-019-0448-y","article-title":"Sleep in Parkinson\u2019s disease.","volume":"45","author":"Stefani","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/brain\/awab005","article-title":"Alpha-synuclein seeds in olfactory mucosa of patients with isolated rapid-eye-movement sleep behaviour disorder.","volume":"144","author":"Stefani","year":"2021","journal-title":"Brain"},{"key":"B51","doi-asserted-by":"publisher","first-page":"466","DOI":"10.15252\/emmm.201506123","article-title":"sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer\u2019s disease and associate with neuronal injury markers.","volume":"8","author":"Su\u00e1rez-Calvet","year":"2016","journal-title":"EMBO Mol. Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.parkreldis.2005.02.006","article-title":"Clinical usefulness of the Parkinson\u2019s disease sleep scale.","volume":"11","author":"Tse","year":"2005","journal-title":"Parkinsonism Relat. Disord"},{"key":"B53","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.neuron.2018.02.018","article-title":"TREM2 and Amyloid Beta: a Love-Hate Relationship.","volume":"97","author":"Udeochu","year":"2018","journal-title":"Neuron"},{"key":"B54","doi-asserted-by":"publisher","first-page":"158.e1","DOI":"10.1016\/j.neurobiolaging.2021.02.024","article-title":"CSF sTREM2 is elevated in a subset in grn-related frontotemporal dementia.","volume":"103","author":"van der Ende","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"B55","doi-asserted-by":"publisher","first-page":"614587","DOI":"10.3389\/fnagi.2020.614587","article-title":"Absence of Uptake and Prion-Like Spreading of Alpha-Synuclein and Tau After Intravitreal Injection of Preformed Fibrils.","volume":"12","author":"Veys","year":"2021","journal-title":"Front. Aging Neurosci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11910-018-0838-2","article-title":"Disturbances of Sleep and Alertness in Parkinson\u2019s Disease.","volume":"18","author":"Videnovic","year":"2018","journal-title":"Curr. Neurol. Neurosci"},{"key":"B57","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target.","volume":"4","author":"Wang","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8834275","article-title":"TREM2 Overexpression Attenuates Cognitive Deficits in Experimental Models of Vascular Dementia.","volume":"2","author":"Wang","year":"2020","journal-title":"Neural Plast"},{"key":"B59","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neurobiolaging.2018.07.011","article-title":"Sleep moderates the relationship between amyloid beta and memory recall.","volume":"71","author":"Wilckens","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"B60","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/brain\/awaa021","article-title":"Soluble TREM2 is elevated in Parkinson\u2019s disease subgroups with increased CSF tau.","volume":"143","author":"Wilson","year":"2020","journal-title":"Brain"},{"key":"B61","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrneurol.2016.203","article-title":"Alzheimer disease: soluble TREM2 in CSF sheds light on microglial activation in AD.","volume":"13","author":"Wood","year":"2017","journal-title":"Nat. Rev. Neurol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.molmed.2017.03.008","article-title":"TREM2, Microglia, and Neurodegenerative Diseases.","volume":"23","author":"Yeh","year":"2017","journal-title":"Trends Mol. Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20160844","article-title":"Soluble TREM2 induces inflammatory responses and enhances microglial survival.","volume":"214","author":"Zhong","year":"2017","journal-title":"J. Exp. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3233\/JAD-181038","article-title":"TREM2 Variants and Neurodegenerative Diseases: A Systematic Review and Meta-Analysis.","volume":"68","author":"Zhou","year":"2019","journal-title":"J. Alzheimers Dis."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2021.753210\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T06:47:18Z","timestamp":1632898038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2021.753210\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":64,"alternative-id":["10.3389\/fnagi.2021.753210"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2021.753210","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,29]]},"article-number":"753210"}}